Floor Backes

Gynecologic Cancer Care: Improving Clinical Trial Enrollment Through Molecular Matching with Targeted Therapies and Improving Access to Care and Research

National Cancer Institute · R50

Contact PI · $396K · Ohio State University

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Principal investigator · Active not recruiting · Early phase 1

Ohio State University Comprehensive Cancer Center

Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Principal investigator · Active not recruiting · Phase 2

Floor Backes, MD

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Principal investigator · Terminated · Early phase 1

Floor Backes, MD

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Principal investigator · Active not recruiting · Phase 3

National Cancer Institute (NCI)